Raythatha Jigar 4
4 · CONSTELLATION PHARMACEUTICALS INC · Filed May 13, 2020
Insider Transaction Report
Form 4
Raythatha Jigar
DirectorSee Remarks10% Owner
Transactions
- Exercise/Conversion
Common Stock
2020-05-11$5.51/sh+26$143→ 14,987 total - Sale
Common Stock
2020-05-11$50.00/sh−26$1,300→ 14,961 total - Exercise/Conversion
Common Stock
2020-05-12$5.51/sh+9,209$50,742→ 24,170 total - Sale
Common Stock
2020-05-12$50.17/sh−9,209$461,981→ 14,961 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-11−26→ 433,149 totalExercise: $5.51Exp: 2027-07-10→ Common Stock (26 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-12−9,209→ 423,940 totalExercise: $5.51Exp: 2027-07-10→ Common Stock (9,209 underlying)
Footnotes (3)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $50.00 to $50.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This option was granted on July 11, 2017. The shares underlying the option are scheduled to vest as to 25% of the shares underlying the option on March 20, 2018, with the remainder vesting in equal quarterly installments through March 20, 2021.